Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
A polysaccharide (PS) purified from venom of the ant Pseudomyrmex sp. causes the activation of the classical complement (C) pathway in normal serum, but not in guinea pig serum. To investigate why C was not activated in guinea pig serum, we partially purified guinea pig C1 in the presence of the protease inhibitor p-nitrophenyl, p'-guanidinobenzoate (NPGB). This C1 preparation was activated (mu = 0.15, pH 7.5) by the PS in a dose-dependent reaction after NPGB was eliminated by dilution. The PS decreased the action of the C1 inhibitor for C1 in diluted guinea pig serum, and it also inhibited the activity of highly purified guinea pig C1 inhibitor for C1. There was a direct correlation between the concentration of the guinea pig C1 inhibitor and the loss of ability of the PS to activate C1 in mixtures of constant concentrations of purified guinea pig C1 and purified venom PS, and increasing concentrations of purified guinea pig C1 inhibitor. The activity of the human C1 inhibitor, either in diluted serum or highly purified, was not decreased by the PS. These results show that the PS does not activate guinea pig C1 in serum because its action is blocked by the C1 inhibitor.
D000818:Animals; D000862:Ant Venoms / Q000494:pharmacology; D003167:Complement Activation / Q000187:drug effects*; D003174:Complement C1 Inactivator Proteins / Q000494:pharmacology*; D003175:Complement C2 / Q000276:immunology*; D003171:Complement Pathway, Classical; D006168:Guinea Pigs; D006801:Humans; D011134:Polysaccharides / Q000494:pharmacology*
D000862:Ant Venoms; D003174:Complement C1 Inactivator Proteins; D003175:Complement C2; D011134:Polysaccharides